Evidence map›Paper›PMID 38802839›Full record

ArticleJournal of translational medicine2024

Correction to: TBC1D5 reverses the capability of HIF‑2 in tumor progression and lipid metabolism in clear cell renal cell carcinoma by regulating the autophagy.

Yu Huang, Zhiyong Xiong, Jianjun Wang, Yafen Gao, Qi Cao, Decai Wang, Jian Shi, Zhixian Chen, Xiong Yang

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Overexpression of CHMP2B suppresses proliferation of renal clear cell carcinoma cells.Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Yu Huang *Department of Urology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Zhiyong Xiong *Department of Urology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Jianjun Wang *Department of Hepatobiliary Surgery, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, China.
Yafen GaoDepartment of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Qi CaoDepartment of Urology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Decai WangDepartment of Urology, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, China.
Jian ShiDepartment of Urology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China. 654568869@qq.com.
Zhixian ChenDepartments of Pathology, Li Ka Shing Faculty of Medicine, School of Clinical Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong, China. chenzx@connect.hku.hk.
Xiong YangDepartment of Urology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China. yangxiong1368@hust.edu.cn.ORCID http://orcid.org/0000-0002-1816-4818

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38802839
PMCPMC11129405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.